Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Christos Bousis, Dimitris Emfietzoglou & Hooshang Nikjoo. (2012) Monte Carlo single-cell dosimetry of I-131, I-125 and I-123 for targeted radioimmunotherapy of B-cell lymphoma. International Journal of Radiation Biology 88:12, pages 908-915.
Read now
Read now
A. Fondell, K. Edwards, J. Unga, E. Kullberg, J. W. Park & L. Gedda. (2011) In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an 125I-labelled DNA-intercalator. Journal of Drug Targeting 19:9, pages 846-855.
Read now
Read now
Junping Cheng, Mikael Persson, Vladimir Tolmachev, Igor Siavaev, Anna Orlova, Kalevi Kairemo & Matti Anniko. (2004) Targeting of a Head and Neck Squamous Cell Carcinoma Xenograft Model Using the Chimeric Monoclonal Antibody U36 Radioiodinated with a closo-Dodecaborate-containing Linker. Acta Oto-Laryngologica 124:9, pages 1078-1085.
Read now
Read now
Vladimir Tolmachev, Jörgen Carlsson & Hans Lundqvist. (2004) A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy
Availability of suitable radionuclides. Acta Oncologica 43:3, pages 264-275.
Read now
Read now
T.E. Wheldon. (1994) Targeting Radiation to Tumours. International Journal of Radiation Biology 65:1, pages 109-116.
Read now
Read now
Sven-Erik Strand, Bo-Anders Jönsson, Michael Ljungberg & Jan Tennvall. (1993) Radioimmunotherapy Dosimetry—A Review. Acta Oncologica 32:7-8, pages 807-817.
Read now
Read now
Anthony Maraveyas & Agamemnon Anthony Epenetos. (1993) Targeted Immunotherapy: An Update with Special Emphasis on Ovarian Cancer. Acta Oncologica 32:7-8, pages 741-746.
Read now
Read now
V. Papanastassiou, B.L. Pizer & J.T. Kemshead. (1993) Application of the Dosimetric Model Described by Humm to Target 131I Monoclonal Antibodies to Leukaemic Cells in the Cerebrospinal Fluid. International Journal of Radiation Biology 63:2, pages 251-254.
Read now
Read now
H. Sakahara, K. Ono, T. Saga, K. Akuta, K. Endo, J. Konishi & M. Abe. (1992) Hepatocyte Response to Continuous Low Dose-rate Radiation in Radioimmunotherapy Assessed by Micronucleus Assay. International Journal of Radiation Biology 62:4, pages 443-448.
Read now
Read now
Articles from other publishers (57)
Vladimir M. Tolmachev, Vladimir I. Chernov & Sergey M. Deyev. (2022) Targeted nuclear medicine. Seek and destroy. Russian Chemical Reviews 91:3, pages RCR5034.
Crossref
Crossref
Baljeet Seniwal, Lucas F Freitas, Bruno M Mendes, Ademar B Lugão, Kattesh V Katti & Telma C F Fonseca. (2021) In silico dosimetry of low-dose rate brachytherapy using radioactive nanoparticles. Physics in Medicine & Biology 66:4, pages 045016.
Crossref
Crossref
Tomer Nawrocki, Thomas C Tritt, Prasad V S V Neti, Alex S Rosen, Akhil R Dondapati & Roger W Howell. (2018) Design and testing of a microcontroller that enables alpha particle irradiators to deliver complex dose rate patterns. Physics in Medicine & Biology 63:24, pages 245022.
Crossref
Crossref
Flonja Liko, François Hindré & Eduardo Fernandez-Megia. (2016) Dendrimers as Innovative Radiopharmaceuticals in Cancer Radionanotherapy. Biomacromolecules 17:10, pages 3103-3114.
Crossref
Crossref
Martin Šefl, Ioanna Kyriakou & Dimitris Emfietzoglou. (2016) Technical Note: Impact of cell repopulation and radionuclide uptake phase on cell survival. Medical Physics 43:6Part1, pages 2715-2720.
Crossref
Crossref
Xuejiao Liu, Cuihua Jiang, Dongjian Zhang, Meng Gao, Fei Peng, Dejian Huang, Ziping Sun, Yicheng Ni, Jian Zhang & Zhiqi Yin. (2015) Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model. Oncotarget 6:28, pages 26400-26410.
Crossref
Crossref
George Nahas, Sarah A. Bliss, Garima Sinha, Teja Ganta, Steven J. Greco & Pranela Rameshwar. (2015) Is reduction of tumor burden sufficient for the 21st century?. Cancer Letters 356:2, pages 149-155.
Crossref
Crossref
Chang Shu Tsai, Wei Chung Liu, Hong Yi Chen & Wei Chun Hsu. (2013) Preparation and Characterization of Fe<sub>3</sub>O<sub>4</sub> Magnetic Nanoparticles Labeled with Technetium-99m Pertectnetate. Applied Mechanics and Materials 459, pages 51-59.
Crossref
Crossref
Wilson H. Y. Roa, Brian Yaremko, Alexander McEwan, John Amanie, Don Yee, John Cho, Steve McQuarrie, Terence Riauka, Ronald Sloboda, Leonard Wiebe, Raimar Loebenberg & Christian Janicki. (2013) Dosimetry Study of [I-131] and [I-125]-Meta-Iodobenzyl Guanidine in a Simulating Model for Neuroblastoma Metastasis. Technology in Cancer Research & Treatment 12:1, pages 79-90.
Crossref
Crossref
Joaquim Bellmunt. (2013) Tackling the Bone with Alpha Emitters in Metastatic Castration-resistant Prostate Cancer Patients. European Urology 63:2, pages 198-200.
Crossref
Crossref
Øyvind S. Bruland & Roy H. Larsen. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
447
457
.
Suresh C. Srivastava & Leonard F. Mausner. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
11
50
.
Brian Lewis & Oliver Sartor. (2012) Radiation-based approaches for therapy and palliation of advanced prostate cancer. Current Opinion in Urology 22:3, pages 183-189.
Crossref
Crossref
Peter L. Roberson, Hanan Amro, Scott J. Wilderman, Anca M. Avram, Mark S. Kaminski, Matthew J. Schipper & Yuni K. Dewaraja. (2010) Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin’s lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 38:5, pages 874-883.
Crossref
Crossref
Uwe Holzwarth. 2011. Radiation Physics for Nuclear Medicine. Radiation Physics for Nuclear Medicine
71
103
.
Sally J. DeNardo, Susan J. Knox & Ignacio Azinovic Gamo. 2010. Leibel and Phillips Textbook of Radiation Oncology. Leibel and Phillips Textbook of Radiation Oncology
1544
1563
.
Brian J McParlandBrian J. McParland. 2010. Nuclear Medicine Radiation Dosimetry. Nuclear Medicine Radiation Dosimetry
401
453
.
C Bousis, D Emfietzoglou, P Hadjidoukas & H Nikjoo. (2009)
A Monte Carlo study of cellular
S
-factors for 1 keV to 1 MeV electrons
. Physics in Medicine and Biology 54:16, pages 5023-5038.
Crossref
Crossref
Alastair J Munro. (2009) Bystander effects and their implications for clinical radiotherapy. Journal of Radiological Protection 29:2A, pages A133-A142.
Crossref
Crossref
R. Rockne, E. C. AlvordJr.Jr., J. K. Rockhill & K. R. Swanson. (2008) A mathematical model for brain tumor response to radiation therapy. Journal of Mathematical Biology 58:4-5.
Crossref
Crossref
Carina Neto, Maria Cristina Oliveira, Lurdes Gano, Fernanda Marques, Isabel Santos, Goreti Ribeiro Morais, Takumi Yasuda, Thies Thiemann, Filomena Botelho & Carlos F. Oliveira. (2009) Radioiodinated ligands for the estrogen receptor: Effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6-dehydroestradiols. Applied Radiation and Isotopes 67:2, pages 301-307.
Crossref
Crossref
Mickaël Bourgeois, François Guerard, Cyrille Alliot, Marie Mougin-Degraef, Holisoa Rajérison, Patricia Remaud-Le Saëc, Jean-François Gestin, François Davodeau, Michel Chérel, Jacques Barbet & Alain Faivre-Chauvet. (2008) Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extraction. Journal of Labelled Compounds and Radiopharmaceuticals 51:11, pages 379-383.
Crossref
Crossref
A Lechner, M Blaickner, S Gianolini, K Poljanc, H Aiginger & D Georg. (2008)
Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a
32
P/
33
P radionuclide cocktail
. Physics in Medicine and Biology 53:7, pages 1961-1974.
Crossref
Crossref
Vladimir Tolmachev. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy
145
174
.
Øyvind S. Bruland, Dahle Jostein, Dag Rune Olsen & Roy H. Larsen. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy
181
194
.
Mikael PerssonIgor SivaevKarl Johan WinbergLars GeddaPer-Uno MalmströmVladimir Tolmachev. (2007)
In Vitro
Evaluation of Two Polyhedral Boron Anion Derivatives as Linkers for Attachment of Radioiodine to the Anti-HER2 Monoclonal Antibody Trastuzumab
. Cancer Biotherapy and Radiopharmaceuticals 22:5, pages 585-596.
Crossref
Crossref
Alexander Stahl, Sylvia Schachoff, Ambros Beer, Anna Winter, Hans Jürgen Wester, Klemens Scheidhauer, Markus Schwaiger & Ingo Wolf. (2006) [111In]DOTATOC as a dosimetric substitute for kidney dosimetry during [90Y]DOTATOC therapy: results and evaluation of a combined gamma camera/probe approach. European Journal of Nuclear Medicine and Molecular Imaging 33:11, pages 1328-1336.
Crossref
Crossref
Emad F. Aziz, Joseph E. Bugaj, Gül Caglar, Ludger M. Dinkelborg & Rüdiger Lawaczeck. (2006) Novel Approach in Radionuclide Tumor Therapy: Dose Enhancement by High Z-Element Contrast Agents. Cancer Biotherapy and Radiopharmaceuticals 21:3, pages 181-193.
Crossref
Crossref
Ylva AlmqvistAnna OrlovaAnna SjöströmHolger J. JensenHans LundqvistAnders SundinVladimir Tolmachev. (2005)
In Vitro
Characterization of
211
At-Labeled Antibody A33—a Potential Therapeutic Agent Against Metastatic Colorectal Carcinoma
. Cancer Biotherapy and Radiopharmaceuticals 20:5, pages 514-523.
Crossref
Crossref
L. Pomorski, Krzysztof Kaczka, S. Piaskowski, I. Wójcik, P. Rieske, M. Matejkowska & K. Kuzdak. (2005) Detection of lymph node metastases of papillary thyroid cancer—comparison of the results of histopathology, immunohistochemistry and reverse transcription-polymerase chain reaction—a preliminary report. Langenbeck's Archives of Surgery 390:3, pages 209-215.
Crossref
Crossref
Rachel K. Bodey, Phil M. Evans & Glenn D. Flux. (2004) Application of the linear-quadratic model to combined modality radiotherapy. International Journal of Radiation Oncology*Biology*Physics 59:1, pages 228-241.
Crossref
Crossref
Mark Lubberink, Hans Lundqvist & Vladimir Tolmachev. (2002)
Production, PET performance and dosimetric considerations of
134
Ce/
134
La, an Auger electron and positron-emitting generator for radionuclide therapy
. Physics in Medicine and Biology 47:4, pages 615-629.
Crossref
Crossref
A. Orlova, A. Sjöström, A. Ericson, O. Lebeda, H. Lundqvist, J. Carlsson & V. Tolmachev. (2001) Cellular processing of indirectly astatinated and iodinated mAb A33 in SW1222 cultured cells. Journal of Labelled Compounds and Radiopharmaceuticals 44:S1, pages S715-S717.
Crossref
Crossref
Robert J Yaes. (2001) Late normal tissue injury from permanent interstitial implants. International Journal of Radiation Oncology*Biology*Physics 49:4, pages 1163-1169.
Crossref
Crossref
Paul Abrams & Alan FritzbergJoseph O’Donoghue. 2000. Radioimmunotherapy of Cancer. Radioimmunotherapy of Cancer
1
20
.
Torbjörn Hartman, Hans Lundqvist, Jan-Erik Westlin & Jörgen Carlsson. (2000) Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with 131I labeled ligands or antibodies. International Journal of Radiation Oncology*Biology*Physics 46:4, pages 1025-1036.
Crossref
Crossref
Martin A. Ebert & Sergei F. Zavgorodni. (2000) Modeling dose response in the presence of spatial variations in dose rate. Medical Physics 27:2, pages 393-400.
Crossref
Crossref
Wynn A. Volkert & Timothy J. Hoffman. (1999) Therapeutic Radiopharmaceuticals. Chemical Reviews 99:9, pages 2269-2292.
Crossref
Crossref
Roy H. Larsen & Øyvind S. Bruland. (1998) Preliminary evaluation of a new radiolabelled biphosphonate. Journal of Labelled Compounds and Radiopharmaceuticals 41:9, pages 823-830.
Crossref
Crossref
Peter Bue, Kenneth Wester, Anna Sjöström, Anders Holmberg, Sten Nilsson, Jörgen Carlsson, Jan-Erik Westlin, Christer Busch & Per-Uno Malmström. (1998) Expression of epidermal growth factor receptor in urinary bladder cancer metastases. International Journal of Cancer 76:2, pages 189-193.
Crossref
Crossref
M.C. Corcoran, J. Eary, I. Bernstein & O.W. Press. (1997) Radioimmunotherapy strategies for non-Hodgkin's lymphomas. Annals of Oncology 8, pages S133-S138.
Crossref
Crossref
Alan E Nahum. (1996) Microdosimetry and radiocurability: modelling targeted therapy with -emitters. Physics in Medicine and Biology 41:10, pages 1957-1972.
Crossref
Crossref
R G Dale. (1996) Dose-rate effects in targeted radiotherapy. Physics in Medicine and Biology 41:10, pages 1871-1884.
Crossref
Crossref
E.B. van Dieren, M.A.B.D. Plaizier, A. van Lingen, J.C. Roos, G.W. Barendsen & G.J.J. Teule. (1996) Absorbed dose distribution of the auger emitters 67Ga and 125I and the β-emitters 67Cu, 90Y, 131I, and 186Re as a function of tumor size, uptake, and intracellular distribution. International Journal of Radiation Oncology*Biology*Physics 36:1, pages 197-204.
Crossref
Crossref
J. L. Humm. 1996. Systemic Radiotherapy with Monoclonal Antibodies. Systemic Radiotherapy with Monoclonal Antibodies
37
65
.
Magnus Essand, Christina Grönvik, Torbjörn Hartman & Jörgen Carlsson. (2006)
Radioimmunotherapy of prostatic adenocarcinomas: Effects of
131
I‐labelled E4 antibodies on cells at different depth in DU 145 spheroids
. International Journal of Cancer 63:3, pages 387-394.
Crossref
Crossref
Roy H. Larsen & Øyvind S. Bruland. (2006) Radiolysis of radioimmunoconjugates. Reduction in antigen‐binding ability by α‐particle radiation. Journal of Labelled Compounds and Radiopharmaceuticals 36:10, pages 1009-1018.
Crossref
Crossref
A. Ullén, B. Nilsson, K. Riklund Åhlström, R. Makiya & T. Stigbrand. (1995) In vivo and in vitro interactions between idiotypic and antiidiotypic monoclonal antibodies against placental alkaline phosphatase. Journal of Immunological Methods 183:1, pages 155-165.
Crossref
Crossref
Zhaochong Zeng & Zhaoyou Tang. (1994) Changes of serum alpha fetoprotein before and after radioimmunotherapy in patients with hepatocellular carcinoma. Chinese Journal of Cancer Research 6:2, pages 83-90.
Crossref
Crossref
Joseph A. O'Donoghue. (1994) The Impact of Tumor Cell Proliferation in Radioimmunotherapy. Cancer 73:S3, pages 974-980.
Crossref
Crossref
Roger M. Macklis, Beverly A. Beresford & John L. Humm. (1994) Radiobiologic studies of low-dose—rate90y-lymphoma therapy. Cancer 73:S3, pages 966-973.
Crossref
Crossref
Anthony Maraveyas & Agamemnon A. Epenetos. 1994. Targeting of Drugs 4. Targeting of Drugs 4
81
90
.
Roger M Macklis, Beverly A Beresford, Sanjeewani Palayoor, Siobhan Sweeney & John L Humm. (1993) Cell cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in lymphoma cells. International Journal of Radiation Oncology*Biology*Physics 27:3, pages 643-650.
Crossref
Crossref
Oliver W. Press, Janet Eary, Frederick R. Appelbaum, Christopher C. Badger & Irwin D. Bernstein. 1993. Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems. Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems
127
145
.
George Sgouros & David A. Scheinberg. 1993. Immunoconjugate Therapy of Hematologic Malignancies. Immunoconjugate Therapy of Hematologic Malignancies
23
64
.
J.A. O'Donoghue. (1991) Optimal scheduling of biologically targeted radiotherapy and total body irradiation with bone marrow rescue for the treatment of systemic malignant disease. International Journal of Radiation Oncology*Biology*Physics 21:6, pages 1587-1594.
Crossref
Crossref
T.E. Wheldon, J.A. O'Donoghue, A. Barrette & A.S. Michalowski. (1991) The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y. Radiotherapy and Oncology 21:2, pages 91-99.
Crossref
Crossref